View |
|
DRP-8767-03
|
Levocetirizine Dihydrochloride
|
Trezin
|
2.5mg/5mL
|
Syrup (Strawberry-Banana Flavor)
|
Antihistamine (Piperazine derivative)
|
Lifesquare Laboratories, Inc.
|
Philippines
|
Initial (CLIDP)
|
26 July 2022
|
13 March 2025
|
View |
DR-XY48223_PI_01.pdf
|
DR-XY48223
|
Edaravone
|
Conjuvon
|
30mg/20mL
|
Solution for IV Infusion
|
Nervous System Drug
|
Simcere Pharmaceutical Co., Ltd.
|
China
|
Monitored Release
|
26 July 2022
|
26 July 2027
|
View |
|
DRP-12334
|
Ascorbic Acid + Zinc
|
Shine-C Forte
|
500mg (equivalent to 562 mg Sodium Ascorbate) /
15mg (equivalent to 105 mg Zinc Gluconate)
|
Capsule
|
Vitamin
|
Interphil Laboratories, Inc.
|
Philippines
|
Initial
|
20 July 2022
|
20 July 2027
|
View |
DRP-12338_PI_01.pdf
|
DRP-12338
|
Ascorbic Acid + Zinc
|
Invictuz
|
500 mg (equivalent to 568.18 mg Sodium Ascorbate)/
10 mg (equivalent to 27.45 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamin/ Mineral
|
San Marino Laboratories Corporation
|
Philippines
|
Initial
|
20 July 2022
|
20 July 2027
|
View |
|
DR-XY48204
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine HC1
(Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Ethneuron Forte
|
300 mg/ 100 mg/ 1000mcg
|
Tablet
|
Vitamins
|
Lejal Laboratories, Inc.
|
Philippines
|
Initial
|
20 July 2022
|
20 July 2027
|
View |
|
DRP-12333
|
Diosmin + Hesperidin
|
Diosmed 1000
|
900 mg/ 100 mg
|
Tablet
|
Vasoprotective
|
Saga Lifesciences Limited
|
India
|
Initial
|
20 July 2022
|
20 July 2027
|
View |
|
DRP-12337
|
Castor Oil
|
Unbranded
|
4.9 mL/ 5 mL
|
Liquid Oil (Strawberry Flavor)
|
Laxative
|
Ace Pharmaceuticals, Inc.
|
Philippines
|
Renewal
|
15 June 2024
|
20 July 2029
|
View |
|
DRP-12335
|
Ascorbic Acid
|
Rapid-C
|
Each 500 mg Chewable Tablet contains: Ascorbic Acid Plain Ascorbic Acid (equivalent to 225 mg Sodium Ascorbate)
300 mg 200 mg
OHILIPP)
|
Chewable Tablet
|
Vitamin
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
20 July 2022
|
20 July 2027
|
View |
|
DRP-12336
|
Ascorbic Acid
|
Ascorgen
|
Each 500 mg Chewable Tablet contains: Ascorbic Acid Plain Ascorbic Acid (equivalent to 225 mg Sodium Ascorbate)
300 mg 200 mg
|
Chewable Tablet
|
Vitamin
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
20 July 2022
|
20 July 2027
|
View |
|
DRP-12174
|
Diosmin + Hesperidin
|
None
|
450 mg/50 mg
|
Film-Coated Tablet
|
Vasoprotective
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
19 July 2022
|
16 June 2027
|
View |
|
DRP-12340
|
Olmesartan Medoxomil
|
Olazura
|
10 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blocker (ARB)
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
20 July 2022
|
20 July 2027
|
View |
|
DRP-12339
|
Olmesartan Medoxomil
|
Olazura
|
20 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blocker (ARB)
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
20 July 2022
|
20 July 2027
|
View |
|
DRP-12327
|
Paclitaxel
|
Taxitas-100
|
6 mg/mL (100 mg/16.7 mL)
|
Concentrate Solution for
I.V. Infusion
|
Antineoplastic (Taxane)
|
ADMAC Lifesciences
|
India
|
Initial (Re application)
|
15 July 2022
|
15 July 2027
|
View |
|
DRP-12358
|
Ascorbic Acid + Zinc + Cholecalciferol (Vitamin D3)
|
Saphceevitd3-OD
|
100 mg/ 10 mg/ 200 I.U. per mL
|
Syrup (Oral Drops)
|
Vitamins and Mineral
|
Enicar Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
26 July 2022
|
26 July 2027
|
View |
|
DRP-12283
|
Multivitamins + Dextrose
|
Dexaminsaph
|
Formulation Each 500 mL contains:
Dextrose Nicotinamide Ascorbic Acid (Vitamin C) D-Panthenol Thiamine Hydrochloride (Vitamin B1) Riboflavin (Vitamin B2) Pyridoxine Hydrochloride (Vitamin B6)
625 mg 500 mg 250 mg 125 mg 25 mg 25 mg
|
Solution for Injection (I.V. Infusion)
|
Parenteral Nutrition
|
Jedux Parenteral Private Limited
|
India
|
Initial
|
21 July 2022
|
21 July 2027
|
View |
|
DRP-12284
|
Multivitamins + Dextrose
|
Dexaminsaph
|
Formulation Each 500 mL contains:
Dextrose-25 g Nicotinamide-625 mg Ascorbic Acid (Vitamin C)-500 mg D-Panthenol-250 mg Thiamine Hydrochloride (Vitamin B1)-125 mg Riboflavin (Vitamin B2)-25mg Pyridoxine Hydrochloride (Vitamin B6)-25mg
|
Solution for Injection (I.V. Infusion)
|
Parenteral Nutrition
|
Althea Pharma Pvt. Ltd.
|
India
|
Initial
|
22 July 2022
|
22 July 2027
|
View |
|
DRP-12309
|
Valsartan
|
Disys 80
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Healthcare Pharmaceuticals Limited
|
Bangladesh
|
Initial
|
21 July 2022
|
21 July 2027
|
View |
|
DRP-12369
|
Ciprofloxacin (As Hydrochloride)
|
Cipromax
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolone)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
26 July 2022
|
26 July 2027
|
View |
|
BRP-112
|
Trastuzumab
|
Ogivri
|
150 mg
|
Lyophilized Powder for Concentrate for Solution
for Infusion (IV)
|
Monoclonal Antibodies (HER2 Inhibitors)
|
Biocon Biologics India Limited
|
India
|
Initial (Re-application)
|
22 July 2022
|
22 July 2027
|
View |
|
BRP-113
|
Trastuzumab
|
Ogivri
|
420 mg
|
Lyophilized Powder for Concentrate for Solution
for Infusion (IV)
|
Monoclonal Antibodies (HER2 Inhibitors)
|
Biocon Biologics India Limited
|
India
|
Initial (Re-application)
|
22 July 2022
|
22 July 2027
|